Clinical Trial Update: TELI COM - Telithromycin in Children With Otitis Media [Phase 3]

View source ↗

Summary

A Phase 3 trial of telithromycin in children with otitis media has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• Telithromycin (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Otitis Media, Suppurative, Otitis Media, Purulent | Phase 3 | Status: TERMINATED